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ABSTRACT: Coronavirus disease (COVID-19) has been increasing slowly and steadily in all the districts of 
Jammu and Kashmir, India. It is essential for the government and health management system to monitor the 
districts affected due to COVID-19. The main objective of this study is to ascertain and categorize the COVID-
19 affected districts into real clusters based on similarities within a cluster and differences among clusters in 
order to imply standard operating procedures (SOPs) policies, decisions, medical facilities, etc. could be 
improved for reducing the risk of infection and death and optimize the deployment of resources for preventing 
subsequent outbreaks. 
Keywords: Clusters; Coronavirus; SARS-CoV-2; Districts; Jammu and Kashmir; Similarities. 
1. INTRODUCTION 
The ongoing outbreak of pandemics caused by a novel coronavirus was originated from the local 
seafood market, Wuhan of Hubei Province, China, in late December 2019 [1-3]. Within a short period, an 
infection spread all over the world [4-6]. On 30th January 2020, the WHO declared this outbreak as a Public 
Health Emergency of International Concern [7-8]. Genetically coronaviruses (CoVs) are a diverse group with 
positive ssRNA as genetic material, enveloped with a protein coat (capsid) [9]. Several organ systems are 
affected by the coronavirus like respiratory, enteric, hepatic, etc., with varying severity among humans and 
animals [10-12]. There are some variants in CoVs such as HCoV‐OC43, HCoV‐229E, HCoVNL63, and 
HCoV‐HKU1, which may cause mild respiratory illness [13-15]. In the past two decades, two nCoVs: 
SARS‐CoV and MERS‐CoV, have emerged, which causes more severe human respiratory infections [16, 17]. 
During the previous outbreak of epidemics caused by SARS‐CoV, there were cases of about 8000 people 
worldwide with nearly ca. 800 deaths, representing a mortality rate of around 10%. Whereas in MERS‐CoV, 
the fatality rate was ca. 35%, caused 334 deaths in 857 officially infected cases. SARS‐CoV is the seventh 
member of the family of CoVs that is zoonotic and infects humans. Fever, fatigue, and cough are the main 
symptoms of COVID‐19, similar to SARS‐CoV and MERS-CoV diseases. There is distinctness in the 
etiology and pathogenesis of these CoVs, which causes severe diseases in humans [18]. 
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On 16th March 2020, the first case of COVID-19 was reported in Jammu and Kashmir (J&K), which 
had a travel history from Saudi Arabia. On the day when the first patient was tested positive for the novel 
coronavirus, the state government declared the disease as an epidemic in the summer capital (Srinagar-SGR) 
of J&K and closed commercial and educational establishments. The district magistrate banned the assemblage 
of people and some other measures. On March 18, 2020, the government imposed section 144 and lockdown 
in the summer capital of Union Territory (J&K) due to an increase in the number of COVID-19 cases. Later 
on 22nd March 2020, the government of India (GoI) declared a 14-hour public curfew and ordered the closure 
of all educational institutions and commercial offices. Further, on 24th March 2020, the government 
announced the nationwide lockdown (phase I) for 21 days and after the completion of phase I lockdown, the 
government extended it up to 3rd May 2020. To stop the spread of coronavirus disease (COVID-19), many 
steps were taken by the state and UT’s government [19]. This study aims to classify and categorize the 
COVID-19 affected districts by clustering based on similarities in confirmed, active cured and death cases. 
This will help the government recognize the most or less affected Jammu and Kashmir districts to optimize 
the screening, lockdown, curfews, and other legal steps in severely affected districts or areas. Furthermore, the 
study will be beneficial in understanding the status of increment in COVID-19 cases across various districts 
and will insight the government, doctors and NGO’s to improve their policies which will be helpful to 
improve the various medical facilities such as ventilators, testing kits and masks that will ultimately reduce 
the spread of infection across the region. 
2. MATERIAL AND METHODS 
2.1. Study area 
Jammu and Kashmir (J&K) is a union territory of India that lies to the north of Himachal Pradesh and 
Punjab and to the west of Ladakh. It has a Mediterranean type of climate. As per Census 2011, J&K 
(including Ladakh) has a population of 1.25 Crores. The Jammu and Kashmir consists of two divisions, each 
comprises of ten districts: Srinagar (SGR), Anantnag (ANG), Bandipora (BD), Baramulla (BR), Ganderbal 
(GD), Budgam (BG), Kulgam (KL), Pulwama (PL), Kupwara (KP), Shopian (SP) are districts of Kashmir 
division. While as Jammu (JM), Ramban (RB), Reasi (RS), Udhampur (UD), Kathua (KT), Kishtwar (KW), 
Poonch (PN), Rajouri (RJ), Samba (SM), Doda (DD) forms the Jammu division. There are 217 Tehsils, 558 
Niabats and 7055 Villages in the UT (including Ladakh as per census 2011). 
2.2. Methodology 
The present study has been divided into three parts. Part I consists of data collection; part II consists of 
a statistical analysis of COVID-19 data set using cluster analysis (Brey-Curtis); and part III consists of 
analysis using radar charts to depict the number of confirmed, active, cured and death cases in each district. 
2.2.1. Part I. Data collection and exploratory analysis 
The data of all cases (confirmed, active, cured and death cases) related to COVID-19 have                   
been retrieved from March 16, 2020, to January 5, 2021, from the website of “COVID-19                 
Monitoring Dashboard maintained by the Ministry of Health and Family Welfare Government of India 
(GoI) [20].  
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From the website of COVID-19 monitoring dashboard, data of all COVID-19 affected districts: 
ANG, BD, BR, BG, DD, GD, JM, KT, KW, KL, KP, PN, PL, RJ, RB, RS, SM, SP, SGR, UD have been 
collected. The data consist of four variables: the number of confirmed, active, cured/discharged and 
death cases. The total number of confirmed, active, cured and death cases during the above-mentioned 
period are 121786, 2684, 117211 and 1891, respectively as given in Table 1. 
 
Table 1. The total number of confirmed, active, cured and death cases from March 16, 2020, to January 5, 2021. 
District Confirmed cases Active cases Cured cases Death cases 
Anantnag (ANG) 4823 108 4632 83 
Bandipora (BD) 4660 58 4542 60 
Baramulla (BR) 8004 120 7712 172 
Badgam (BG) 7644 108 7426 110 
Doda (DD) 3398 45 3289 64 
Ganderbal GD) 4500 81 4375 44 
Jammu (JM) 24058 677 23024 357 
Kathua (KT) 3214 42 3123 49 
Kishtwar (KW) 2722 13 2688 21 
Kulgam (KL) 2666 57 2556 53 
Kupwara (KP) 5571 123 5357 91 
Poonch (PN) 2462 41 2397 24 
Pulwama (PL) 5600 151 5361 88 
Rajouri (RJ) 3846 128 3664 54 
Ramban (RB) 2113 22 2070 21 
Reasi (RS) 1628 12 1601 15 
Samba (SM) 2775 202 2534 39 
Shopian (SP) 2524 107 2378 39 
Srinagar (SGR) 25482 537 24495 450 
Udhampur (UD) 4096 52 3987 57 
Total 121786 2684 117211 1891 
 
2.2.2. Part II. Cluster analysis (CS) 
Cluster analysis is one of the best data analyzing techniques by which the sample variables are 
clustered into groups based on their similarities within a group and dissimilarities among different 
groups [21, 22]. The Bray-Curtis method is the robust and most conventionally used method that does 
not require prior postulation and uses variance analysis to calculate similarities among different clusters 
[23, 24]. This study used the OriginPro software (version OriginPro 2019b-64 bit) to accomplish the 
cluster analysis. The data set has been scaled properly before executing the cluster analysis. 
2.2.3. Part III. Analysis using a radar chart 
To show the increment of all the variables (cases), we plot the radar charts by analyzing the data set 
statistically using the PAST software (version 3). The radar charts are given in Figures 5-8. It is well 
known that these plots are easy to understand the values/increments of each variable. 
Pandey et al.   Use of statistical analysis to monitor novel coronavirus-19 cases in India 277 
 
European Journal of Biological Research 2021; 11(3): 274-282 
3. RESULTS AND DISCUSSION 
Results obtained from the current study suggested four dendrograms (Figures 1-4) for each 
variable (confirmed, active, cured and death cases). For the visual representation, these dendrograms of 
cluster analysis calculated separately from all the variables of the COVID-19 data set. For confirmed 
cases, districts like ANG, BD and GD; BG and BR; SGR and JM; SM and KW; PL and KP; KT and 
DD; UD and RJ; SP and PN. For active cases, districts like SGR and JM; RS and KW; PN and KT; KL 
and BD; KP and BR; BG and ANG. For cured cases, districts like SGR and JM; BG and BR; SP and PN; 
SM and KL; PL and KP; KT and DD; UD and RJ; BG and ANG. While as for death cases, districts like 
SGR and JM; RB and KW; SP and SM; RJ and KL; UD and BD; PL and KP forming clusters based on 
their similarity in COVID-19 cases as shown in Figures 1-4. 
 
 
Figure 1. Dendrogram showing clustering of districts for confirmed cases of coronavirus disease (COVID-19). 
 
 
Figure 2. Dendrogram showing clustering of districts for active cases of coronavirus disease (COVID-19). 
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Figure 3. Dendrogram showing clustering of districts for cured cases of coronavirus disease (COVID-19). 
 
 
Figure 4. Dendrogram showing clustering of districts for death cases of coronavirus disease (COVID-19). 
ANG - Anantnag; SGR - Srinagar; BD - Bandipora; BR - Baramulla; GD - Ganderbal; BG - Budgam; KL - Kulgam; PL - Pulwama;                          
KP - Kupwara; SP - Shopian; JM - Jammu, RB - Ramban; RS - Reasi, UD - Udhampur; KT - Kathua; KW - Kishtwar; PN - Poonch;                              
RJ - Rajouri; SM - Samba; DD - Doda. 
 
 All the districts of J&K have a high burden of confirmed cases. Districts like ANG, BR, BD, JM, 
KP, PL, RJ, SM, SGR and SP still have a good percentage of active cases. However, ANG, BP, BR, BD, 
JM, SGR, PL and KP have high rates of cured cases. While ANG, BP, BR, JM, SGR, PL and KP show a 
high rate of mortality. The trend shown in radar charts (Figures 5-8) for all the variables (confirmed, 
active, cured and death cases) related to COVID-19 were directly proportional; the districts with a high 
percentage of confirmed or active cases had a high number of cured as well as death cases. 
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Figure 7. Radar chart showing cured cases of coronavirus disease (COVID-19). 
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Figure 8. Radar chart showing death cases of coronavirus disease (COVID-19). 
 
 The radar chart (Figure 5) showed that all the districts had a good percentage of confirmed COVID-19 
cases, but districts like SGR, JM, BR and BG were in the severe zone. Similarly, in other radar charts (Figures 
6-8), districts like SGR, JM, BR, BG, SM, PL and RJ showed a high number of active cases. Similarly, 
districts like SGR, JM, RJ, PL and KP showed severity in death cases. Few studies are based unequivocally on 
Indian COVID-19 data. Kumar [25] has used cluster analyzing to monitor the novel COVID-19 cases in 
Maharashtra, India. Das [26] has used the epidemiological model to estimate the basic reproduction number at 
national and some state levels. Ray et al. [27] used a predictive model for case counts in India. Considering 
the great diversity in every aspect of India and its vast population, it would be a much better idea to monitor 
the COVID-19 cases at each of the states individually. It would help to decide further plans and actions to 
contain the spread of the disease, which can be crucial for the COVID-19 affected states 
4. CONCLUSIONS 
 In this study, hierarchical (Brey-Curtis) cluster analysis was carried out to classify districts of Jammu 
and Kashmir based on similarity among COVID-19 cases to visually understand the impact of COVID-19. 
This technique grouped 20 different affected districts into four cluster and radar charts for each of the cases 
(variables). All the districts of J&K under clusters (Figure 1 & 5) were affected severely with COVID-19. 
The radar charts (Figures 5-8) showed the number of confirmed, active, cured and death cases, respectively. 
The trend in radar charts depicted a good percentage of cured cases in some districts: ANG, BP, BRA, BD, 
JM, SGR, PL and KP. It was also observed that the districts like SGR, JM, SM and PL have higher cases 
may need optimization of monitoring techniques which could help the government in making better policies 
and actions. 
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